Article Information
History
- July 18, 2017.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Matthias A. Roelli1,
- Dorothée Ruffieux-Daidié1,
- Amandine Stooss1,
- Oussama ElMokh1,
- Wayne A. Phillips3,
- Matthias S. Dettmer2 and
- Roch-Philippe Charles1
- 1Institut für Biochemie und Molekulare Medizin, Universität Bern, Bern, Switzerland
- 2Institut für Pathologie, Universität Bern, Bern, Switzerland
- 3Cancer Biology Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia
- Corresponding author: Roch-Philippe Charles, Institute für Biochemie und Molekular Medizin, Universität Bern, Bühlstrasse28, CH-3012 Bern, Switzerland.Phone: +41 31 631 4344 Email:roch-philippe.charles{at}ibmm.unibe.ch
Posted July 18, 2017.
PIK3CAH1047R-induced paradoxical ERK activation results in resistance to BRAFV600E specific inhibitors in BRAFV600E PIK3CAH1047R double mutant thyroid tumors
